Total planned funding: $9,008,223

Allocations

$9,008,223

$9,008,223

HTXD: Treatment: ARV Drugs	$3,200,000
HTXS: Treatment: Adult Treatment	$1,964,779
PDTX: Treatment: Pediatric Treatment	$1,631,832
HMBL: Biomedical Prevention: Blood Safety	$1,066,713
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission	$644,899
HVCT: Testing: HIV Testing and Counseling	$500,000
HMIN: Biomedical Prevention: Injection Safety	$0
HBHC: Care: Adult Care and Support	$0
HVTB: Care: TB/HIV	$0
HLAB: Laboratory Infrastructure	$0

View countries

2013	$9,008,223